search
Back to results

Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial

Primary Purpose

Hot Flashes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Hypnosis
Structured attention
Sponsored by
Baylor University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hot Flashes focused on measuring hot flashes, post menopausal women, skin conductance monitors, hypnosis, hypnotizability

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Postmenopausal as defined by:

    1. no menstrual period in the past 12 months;
    2. no menstrual period in the past 6 months and a medically documented history of FSH level greater than 40; or
    3. women who have had a bilateral oophorectomy.
  • A self-reported history of a minimum of 7 hot flashes per day or 50 hot flashes per week at baseline.
  • Age over 18 years and ability to give her own consent for participation in the study.
  • Have discontinued other putative therapies for hot flashes for at least one month prior to enrollment
  • Ability to attend weekly sessions.

Exclusion Criteria:

  • Receiving other simultaneous treatment for hot flashes.
  • Using any CAM (Complementary and Alternative Medicine) treatments for vasomotor symptoms • Any medical or psychiatric condition that in the opinion of the investigator puts the participant at potential risk during the study.
  • Currently using hypnosis for any reason.
  • Inability to speak or understand English

Sites / Locations

  • Mind-Body Medicine Research Lab-Baylor University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Hypnosis

Structured Attention

Arm Description

Receives 5 weeks of hypnotic relaxation therapy

Meets with therapist for five weekly sessions, but receives no hypnotic relaxation therapy

Outcomes

Primary Outcome Measures

Hot Flash Frequency
The Hot Flash Symptoms Diary was used to measure hot flash frequency. Participants recorded their hot flashes over seven days by daily frequency and severity. This instrument provides a measure of hot flash frequency and hot flash score (product of frequency x severity).
Hot Flash Score
Hot Flash Score is a product of frequency of hot flashes × severity of hot flashes, which could range from 0 (best possible outcome) to infinity (worst possible outcome). Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their daily hot flashes marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4). The values presented represent the average of daily hot flash scores.
Hot Flash Related Daily Interference Scale (HFRDIS)
This questionnaire is used to measure the effects of hot flashes on women as they go about their daily activities. Answers on the scale can range 0 (Do Not Interfere) to 10 (Completely Interfere). The total score was computed by averaging the subjective ratings over the 10 items. A lower score indicates better outcome.

Secondary Outcome Measures

Sternal Skin Conductance Monitor Used to Physiologically Measure Skin Moisture
As a secondary outcome, hot flashes were measured using a Biolog ambulatory recorder. Skin conductance was expressed in micro Siemens (0 to infinity) and the final value was obtained by averaging the recorded skin conductance for a period of 24 hours. Lower skin conductance measure indicates less sweating.
Pittsburg Sleep Quality Index (PSQI)
The Pittsburg Sleep Quality Index (PSQI) is a self-report inventory designed to measure sleep quality. The participants self rate their sleep quality over seven areas of sleep.The questions about sleep quality are answered on a 0-3 scale with higher scores indicating greater sleep pathology. The global score is determined by summing the raw scores of the seven sleep components. The global score can range from 0 - 21 and total scores above 5 are normally considered indicative of poor sleep quality.

Full Information

First Posted
February 10, 2011
Last Updated
July 18, 2016
Sponsor
Baylor University
Collaborators
National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT01293695
Brief Title
Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial
Official Title
Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Completed
Study Start Date
September 2007 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baylor University
Collaborators
National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is designed to determine the effect of a Hypnosis Intervention on reducing hot flash frequency (perceived impact vs. physiologically measured impact), severity and daily interference in post-menopausal women. It is felt that the Hypnosis Intervention will result in significantly lower hot flash frequency, severity and daily interference scores (perceived impact vs. physiologically measured impact) versus Structured-Attention Control.
Detailed Description
The aging population of the United States and findings from the Women's Health Initiative that indicate a shift in the risk/benefits balance of hormone therapy have created a growing interest in alternative treatments for hot flashes. Hot flashes are among the most severe and frequent symptoms experienced by women during menopause. Over 66% of post-menopausal women experience hot flashes. As a result, there is a pressing need for safe and effective treatments for hot flashes. Hypnosis is one mind-body therapy that seems particularly promising for treating hot flashes. However, the treatment effectiveness of hypnosis in reducing physiologically measured (i.e. physiologically measured impact) hot flashes with post-menopausal women has yet to be established relative to a Structured-Attention Control. This is a critical step to further investigate the intervention and to determine if hypnosis reduces the symptoms (i.e. the number of physiological hot flashes) or only the women's perception of symptoms. Also, the physiologic mechanism by which hypnosis may operate in reducing hot flashes is not known. The present study will compare hypnosis to a Structured-Attention Control in reducing hot flashes (perceived and physiologically monitored) in post-menopausal women in a randomized clinical trial. Innovations of this study are that it will be the first full scale test of hypnosis for hot flashes; one of the first studies to examine both perceived impact and physiologically measured impact of a mind-body intervention for hot flashes using state-of-the-art 24 hour ambulatory physiological monitoring; the first study to examine the effect of hypnosis for hot flashes on cortisol; and the first investigation of the role of cognitive expectancies in treatment of hot flashes in comparison to a Structured-Attention Control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hot Flashes
Keywords
hot flashes, post menopausal women, skin conductance monitors, hypnosis, hypnotizability

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
187 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hypnosis
Arm Type
Active Comparator
Arm Description
Receives 5 weeks of hypnotic relaxation therapy
Arm Title
Structured Attention
Arm Type
Placebo Comparator
Arm Description
Meets with therapist for five weekly sessions, but receives no hypnotic relaxation therapy
Intervention Type
Behavioral
Intervention Name(s)
Hypnosis
Other Intervention Name(s)
Hypnotic relaxation therapy, Hypnosis relaxation, Hypnotic intervention, Hypnosis intervention
Intervention Description
Hypnosis relaxation in five weekly sessions
Intervention Type
Other
Intervention Name(s)
Structured attention
Other Intervention Name(s)
Placebo Comparator
Intervention Description
Meets with therapist for five weekly sessions and receives structured attention/supportive counseling, but receives no hypnotic relaxation therapy
Primary Outcome Measure Information:
Title
Hot Flash Frequency
Description
The Hot Flash Symptoms Diary was used to measure hot flash frequency. Participants recorded their hot flashes over seven days by daily frequency and severity. This instrument provides a measure of hot flash frequency and hot flash score (product of frequency x severity).
Time Frame
6 Weeks and 12 Weeks
Title
Hot Flash Score
Description
Hot Flash Score is a product of frequency of hot flashes × severity of hot flashes, which could range from 0 (best possible outcome) to infinity (worst possible outcome). Hot flash frequency and hot flash severity were obtained using the Hot Flash Symptoms Diary. Participants recorded their daily hot flashes marking each hot flash (frequency) and rating the severity of each as mild (1), moderate (2), severe (3), and very severe (4). The values presented represent the average of daily hot flash scores.
Time Frame
6 Weeks and 12 Weeks
Title
Hot Flash Related Daily Interference Scale (HFRDIS)
Description
This questionnaire is used to measure the effects of hot flashes on women as they go about their daily activities. Answers on the scale can range 0 (Do Not Interfere) to 10 (Completely Interfere). The total score was computed by averaging the subjective ratings over the 10 items. A lower score indicates better outcome.
Time Frame
6 Weeks and 12 Weeks
Secondary Outcome Measure Information:
Title
Sternal Skin Conductance Monitor Used to Physiologically Measure Skin Moisture
Description
As a secondary outcome, hot flashes were measured using a Biolog ambulatory recorder. Skin conductance was expressed in micro Siemens (0 to infinity) and the final value was obtained by averaging the recorded skin conductance for a period of 24 hours. Lower skin conductance measure indicates less sweating.
Time Frame
6 Weeks and 12 Weeks
Title
Pittsburg Sleep Quality Index (PSQI)
Description
The Pittsburg Sleep Quality Index (PSQI) is a self-report inventory designed to measure sleep quality. The participants self rate their sleep quality over seven areas of sleep.The questions about sleep quality are answered on a 0-3 scale with higher scores indicating greater sleep pathology. The global score is determined by summing the raw scores of the seven sleep components. The global score can range from 0 - 21 and total scores above 5 are normally considered indicative of poor sleep quality.
Time Frame
6 Weeks and 12 Weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Postmenopausal as defined by: no menstrual period in the past 12 months; no menstrual period in the past 6 months and a medically documented history of FSH level greater than 40; or women who have had a bilateral oophorectomy. A self-reported history of a minimum of 7 hot flashes per day or 50 hot flashes per week at baseline. Age over 18 years and ability to give her own consent for participation in the study. Have discontinued other putative therapies for hot flashes for at least one month prior to enrollment Ability to attend weekly sessions. Exclusion Criteria: Receiving other simultaneous treatment for hot flashes. Using any CAM (Complementary and Alternative Medicine) treatments for vasomotor symptoms • Any medical or psychiatric condition that in the opinion of the investigator puts the participant at potential risk during the study. Currently using hypnosis for any reason. Inability to speak or understand English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gary R Elkins, Ph.D.
Organizational Affiliation
Baylor University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mind-Body Medicine Research Lab-Baylor University
City
Waco
State/Province
Texas
ZIP/Postal Code
76798
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34403019
Citation
Roberts RL, Rhodes JR, Elkins GR. Effect of Hypnosis on Anxiety: Results from a Randomized Controlled Trial with Women in Postmenopause. J Clin Psychol Med Settings. 2021 Dec;28(4):868-881. doi: 10.1007/s10880-021-09810-3. Epub 2021 Aug 17.
Results Reference
derived
PubMed Identifier
21989181
Citation
Elkins GR, Fisher WI, Johnson AK. Hypnosis for hot flashes among postmenopausal women study: a study protocol of an ongoing randomized clinical trial. BMC Complement Altern Med. 2011 Oct 11;11:92. doi: 10.1186/1472-6882-11-92.
Results Reference
derived

Learn more about this trial

Hypnosis For Hot Flashes Among Postmenopausal Women in a Randomized Clinical Trial

We'll reach out to this number within 24 hrs